Newborn screening for cystic fibrosis (CF) was fully implemented in all 50 states in the U.S. by 2010, but delays in timeliness of evaluation for infants with positive newborn screen tests persist. Through evaluation of national ...
Jul 31, 2023
0
1
The RNF41 protein could be a new therapeutic target in the fight against two chronic liver diseases: cirrhosis and liver inflammation. This is the conclusion of a study published in the journal Science Translational Medicine ...
Jul 28, 2023
0
340
Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology.
Jul 21, 2023
0
25
A scorpionfish protein could prove a powerful tool for treating multidrug-resistant bacterial infections in people with cystic fibrosis, according to a preliminary study published today in eLife.
Jul 18, 2023
0
18
The mucus in the airways is not as sticky, and inflammation in the lungs is significantly reduced: Triple combination therapy can achieve these positive, lasting effects in patients with cystic fibrosis (CF). Researchers ...
Jul 7, 2023
0
10
Researchers from Griffith University's NatureBank and Metro North Health in Brisbane have found a natural product derived from a Queensland rainforest tree that may hold the key to treating and reversing life-threatening ...
Jul 5, 2023
0
1
Black people face a higher risk of developing severe liver fibrosis, but a new study suggests personalized care could help mitigate that risk.
Jul 5, 2023
0
0
Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis.
Jun 26, 2023
0
102
Yale researchers have found that liver fibrosis—scarring of the liver tissue that occurs in many chronic liver diseases—is associated with reduce cognitive ability and, in certain regions of the brain, reduced brain volume. ...
Jun 26, 2023
0
86
A newly developed PET imaging agent, 64Cu-GPVI-Fc, can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to begin treatment sooner. This research ...
Jun 21, 2023
0
5
